Swiss companies invested $27 billion in the United States during the first four months of the year, underscoring the rapid pace at which Switzerland is delivering on a landmark investment pledge made as part of a tariff agreement with Washington.
According to Swiss newspaper NZZ am Sonntag, which cited an internal email from the Swiss-American Chamber of Commerce, the January-to-April investment total represents an early indication that Swiss corporations are moving aggressively to expand their U.S. footprint after President Donald Trump’s administration agreed to lower tariffs on Swiss goods.
The investment push follows a preliminary agreement announced on November 14 under which Swiss companies committed to invest $200 billion in the United States over five years. In return, Washington reduced tariffs on Swiss exports to 15% from 39%, easing concerns among Swiss manufacturers and exporters that higher trade barriers could undermine access to one of their most important markets.
If the current pace is maintained, Swiss investment could significantly exceed the original commitment, highlighting how trade policy is increasingly influencing global capital allocation decisions.
The investments span pharmaceuticals, medical technology, manufacturing, logistics, and transportation, sectors that form the backbone of Switzerland’s export-oriented economy. Among the largest contributors are pharmaceutical giants Novartis and Roche, both of which are expanding their U.S. operations as demand for advanced medicines and biotechnology manufacturing continues to grow.
Novartis has announced plans for a biomedical research center in San Diego and a cancer-drug production facility in Texas, while Roche is expanding manufacturing capacity in North Carolina. Medical technology company Ypsomed is also constructing a new U.S. factory, strengthening Switzerland’s growing healthcare manufacturing presence in America.
The investments are not limited to healthcare.
Shipping giant MSC is establishing a new North American headquarters in Miami while expanding its cruise and logistics operations, reflecting confidence in long-term U.S. consumer demand and trade activity. Industrial firms such as machine-tool manufacturer Pfiffner Group and electronics company Elma are also increasing production capacity in the United States to serve local customers and reduce exposure to potential trade disruptions.
Swiss-American Chamber of Commerce Chief Executive Rahul Sahgal said the investment figures demonstrate that Swiss businesses are acting on the commitments made during negotiations with Washington.
“We are model students and we fulfil our promises,” Sahgal was quoted as saying.
Faced with rising geopolitical tensions, supply-chain vulnerabilities, and increasingly strategic trade policies, multinational corporations are investing closer to key markets rather than relying solely on global production networks.
For Swiss firms, the United States remains particularly attractive. The country offers the world’s largest consumer market, substantial government incentives for advanced manufacturing, deep capital markets, and a growing push to localize critical industries such as pharmaceuticals, biotechnology, and semiconductors.
The Swiss expansion also comes at a time when European companies are seeking greater certainty in an increasingly fragmented global economy. While Europe remains an important market, slower economic growth and regulatory complexity have prompted many firms to prioritize North America for new investments.
The developments highlight the growing use of investment commitments as a bargaining tool in international trade negotiations. Rather than focusing solely on tariffs, governments are increasingly linking market access to promises of domestic investment, job creation, and industrial development.
However, new trade risks remain on the horizon.
Washington recently announced additional tariffs targeting countries it believes are not doing enough to combat forced labor. Under the proposed measure, Swiss goods would face a 12.5% tariff, compared with 10% for products from the European Union.
Although the new tariff would remain well below the punitive 39% rate initially imposed on Swiss goods, it signals that trade tensions could continue to influence business decisions and investment strategies.
For now, Swiss corporations appear determined to deepen their U.S. presence. The early investment figures suggest that the tariff agreement has evolved beyond a trade deal into a catalyst for one of the largest waves of Swiss corporate investment in the United States in recent years.
The scale of the commitment also backs the importance of Switzerland to the U.S. economy. While often viewed primarily as a financial center, Switzerland is one of the largest foreign investors in the United States, supporting hundreds of thousands of jobs through its pharmaceutical, manufacturing, logistics, and technology operations.
However, as Washington continues to use trade policy to attract foreign capital and strengthen domestic industry, the Swiss investment surge is expected to become a model for future economic agreements, where market access is exchanged for long-term commitments to invest, manufacture, and create jobs on American soil.
